Angel Cooper

793 total citations
16 papers, 607 citations indexed

About

Angel Cooper is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Angel Cooper has authored 16 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 9 papers in Molecular Medicine and 5 papers in Epidemiology. Recurrent topics in Angel Cooper's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (9 papers) and Pneumonia and Respiratory Infections (5 papers). Angel Cooper is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (9 papers) and Pneumonia and Respiratory Infections (5 papers). Angel Cooper collaborates with scholars based in United States, United Kingdom and Estonia. Angel Cooper's co-authors include Gary Dukart, Timothy Babinchak, Nathalie Dartois, David Gardiner, P. Whittlestone, D.R. Wise, J Fuller, Sujata M. Bhavnani, Joan Korth‐Bradley and Alan Forrest and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Angel Cooper

16 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angel Cooper United States 13 322 303 173 120 106 16 607
Giovanni Bonfiglio Italy 18 433 1.3× 252 0.8× 196 1.1× 96 0.8× 78 0.7× 41 807
D. Sofianou Greece 16 616 1.9× 168 0.6× 278 1.6× 151 1.3× 228 2.2× 39 1.1k
Maria Bagattini Italy 15 494 1.5× 95 0.3× 173 1.0× 71 0.6× 133 1.3× 22 789
Karen Amsler United States 10 231 0.7× 233 0.8× 157 0.9× 60 0.5× 257 2.4× 15 593
J. Prieto Spain 18 300 0.9× 397 1.3× 483 2.8× 79 0.7× 318 3.0× 79 1.0k
Jiso Ryu South Korea 10 312 1.0× 122 0.4× 264 1.5× 107 0.9× 152 1.4× 20 608
Jean Li Yan United States 13 234 0.7× 238 0.8× 226 1.3× 74 0.6× 198 1.9× 28 546
G. Poulakou Greece 8 616 1.9× 427 1.4× 350 2.0× 123 1.0× 68 0.6× 10 781
Francesca Ginocchio Italy 10 789 2.5× 446 1.5× 320 1.8× 257 2.1× 134 1.3× 14 1.1k
Scott A. Van Wart United States 19 353 1.1× 548 1.8× 324 1.9× 110 0.9× 349 3.3× 33 901

Countries citing papers authored by Angel Cooper

Since Specialization
Citations

This map shows the geographic impact of Angel Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angel Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angel Cooper more than expected).

Fields of papers citing papers by Angel Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angel Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angel Cooper. The network helps show where Angel Cooper may publish in the future.

Co-authorship network of co-authors of Angel Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Angel Cooper. A scholar is included among the top collaborators of Angel Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angel Cooper. Angel Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Embil, John M., et al.. (2013). Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis. Diagnostic Microbiology and Infectious Disease. 78(4). 469–480. 72 indexed citations
2.
Ramírez, Julio A., et al.. (2012). Switch therapy in hospitalized patients with community-acquired pneumonia: Tigecycline vs. Levofloxacin. BMC Infectious Diseases. 12(1). 159–159. 9 indexed citations
3.
Rubino, Christopher M., Sujata M. Bhavnani, Alan Forrest, et al.. (2011). Pharmacokinetics-Pharmacodynamics of Tigecycline in Patients with Community-Acquired Pneumonia. Antimicrobial Agents and Chemotherapy. 56(1). 130–136. 41 indexed citations
4.
Chuang, Yin-Ching, et al.. (2011). Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan. Journal of Microbiology Immunology and Infection. 44(2). 116–124. 13 indexed citations
5.
Chen, Zhangjing, Jufang Wu, Yingyuan Zhang, et al.. (2010). Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial. BMC Infectious Diseases. 10(1). 217–217. 36 indexed citations
6.
Rubino, Christopher M., Alan Forrest, Sujata M. Bhavnani, et al.. (2010). Tigecycline Population Pharmacokinetics in Patients with Community- or Hospital-Acquired Pneumonia. Antimicrobial Agents and Chemotherapy. 54(12). 5180–5186. 34 indexed citations
7.
Gardiner, David, Gary Dukart, Angel Cooper, & Timothy Babinchak. (2009). Safety and Efficacy of Intravenous Tigecycline in Subjects with Secondary Bacteremia: Pooled Results from 8 Phase III Clinical Trials. Clinical Infectious Diseases. 50(2). 229–238. 73 indexed citations
8.
Teras, Jüri, Jānis Gardovskis, T. Vaasna, et al.. (2008). Overview of Tigecycline Efficacy and Safety in the Treatment of Complicated Skin and Skin Structure Infections - A European Perspective. Journal of Chemotherapy. 20(sup1). 20–27. 10 indexed citations
9.
10.
Bergallo, Carlos, Abel Jasovich, María Eugenia Oliva, et al.. (2008). Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin. Diagnostic Microbiology and Infectious Disease. 63(1). 52–61. 73 indexed citations
11.
Cooper, Angel, et al.. (2008). The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra-Adominal Infections - The European Experience. Journal of Chemotherapy. 20(sup1). 12–19. 16 indexed citations
12.
13.
Cooper, Angel, et al.. (1993). In vitro activity of danofloxacin, tylosin and oxytetracycline against mycoplasmas of veterinary importance. Research in Veterinary Science. 54(3). 329–334. 57 indexed citations
14.
Jordan, F. T. W., et al.. (1993). A comparison of the efficacy of danofloxacin and tylosin in the control of Mycoplasma gallisepticum infection in broiler chicks. Journal of Veterinary Pharmacology and Therapeutics. 16(1). 79–86. 18 indexed citations
15.
Kempf, Isabelle, et al.. (1992). Efficacy of danofloxacin in the therapy of experimental mycoplasmosis in chicks. Research in Veterinary Science. 53(2). 257–259. 24 indexed citations
16.
Grimshaw, W. T. R., C. Giles, Angel Cooper, & D.J Shanks. (1990). The efficacy of danofloxacin in the therapy of pneumonia associated with Pasteurella species in housed calves.. PubMed. 97(12). 529–32. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni Bonfiglio Breakdown of academic impact, for papers by D. Sofianou Breakdown of academic impact, for papers by Maria Bagattini Breakdown of academic impact, for papers by Karen Amsler Breakdown of academic impact, for papers by J. Prieto Breakdown of academic impact, for papers by Jiso Ryu Breakdown of academic impact, for papers by Jean Li Yan Breakdown of academic impact, for papers by G. Poulakou Breakdown of academic impact, for papers by Francesca Ginocchio Breakdown of academic impact, for papers by Scott A. Van Wart
Rankless by CCL
2026